Notice of Receipt of Complaint; Solicitation of Comments Relating to the Public Interest, 1785-1787 [2019-01120]
Download as PDF
<![CDATA[
Federal Register / Vol. 84, No. 24 / Tuesday, February 5, 2019 / Notices
18, 2018 (83 FR 33946).3 The hearing
was held in Washington, DC, on October
30, 2018, and all persons who requested
the opportunity were permitted to
appear in person or by counsel.
The Commission made these
determinations pursuant to sections
705(b) and 735(b) of the Act (19 U.S.C.
1671d(b) and 19 U.S.C. 1673d(b)). It
completed and filed its determinations
in these investigations on January 30,
2019. The views of the Commission are
contained in USITC Publication 4861
(January 2019), entitled Common Alloy
Aluminum Sheet from China:
Investigation Nos. 701–TA–591 and
731–TA–1399 (Final).
By order of the Commission.
Issued: January 30, 2019.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2019–01069 Filed 2–4–19; 8:45 am]
BILLING CODE 7020–02–P
INTERNATIONAL TRADE
COMMISSION
[Investigation Nos. 701–TA–593 and 594
and 731–TA–1402 and 1404 (Final)]
Large Diameter Welded Pipe From
China and India; Determinations
developed
On the basis of the
in the subject investigations, the United
States International Trade Commission
(‘‘Commission’’) determines,2 pursuant
to the Tariff Act of 1930 (‘‘the Act’’),
that an industry in the United States is
materially injured by reason of imports
of carbon and alloy (other than
stainless) steel large diameter welded
line pipe from India provided for in
subheadings 7305.11.10, 7305.11.50,
7305.12.10, 7305.12.50, 7305.19.10, and
7305.19.50 of the Harmonized Tariff
Schedule of the United States
(‘‘HTSUS’’) that have been found by the
U.S. Department of Commerce
(‘‘Commerce’’) to be sold in the United
States at less than fair value (‘‘LTFV’’)
and subsidized by the government of
record 1
3 Due to the lapse in appropriations and ensuing
cessation of Commission operations, all import
injury investigations conducted under authority of
Title VII of the Tariff Act of 1930 accordingly have
been tolled pursuant to 19 U.S.C. 1671d(b)(2),
1673d(b)(2).
1 The record is defined in sec. 207.2(f) of the
Commission’s Rules of Practice and Procedure (19
CFR 207.2(f)).
2 Commissioner Meredith M. Broadbent
dissenting with respect to the affirmative
determinations regarding imports of carbon and
alloy (other than stainless) steel large diameter
welded line pipe from China and India.
Commissioner Jason E. Kearns voting in the
affirmative with respect to carbon and alloy (other
than stainless) steel large diameter welded pipe
from China and India.
VerDate Sep<11>2014
17:22 Feb 04, 2019
Jkt 247001
India. The Commission also determines
that an industry in the United States is
threatened with material injury by
reason of LTFV imports of carbon and
alloy (other than stainless) steel large
diameter welded line pipe from China.
Further, the Commission terminates the
countervailing duty investigation on
carbon and alloy (other than stainless)
steel large diameter welded line pipe
from China.
The Commission also determines that
an industry in the United States is
materially injured by reason of imports
of carbon and alloy (other than
stainless) steel large diameter welded
structural pipe from China provided for
in subheadings 7305.31.40, 7305.31.60,
7305.39.10, and 7305.39.50 of the HTS
that have been found by Commerce to
be sold in the United States at LTFV and
subsidized by the government of China.
In addition, the Commission terminates
the antidumping and countervailing
duty investigations on carbon and alloy
(other than stainless) steel large
diameter welded structural pipe from
India.
Finally, the Commission determines
that an industry in the United States is
not materially injured or threatened
with material injury by reason of
imports of stainless steel large diameter
welded pipe from China and India
provided for in subheading 7305.31.60
of the HTSUS, that have been found by
Commerce to be sold in the United
States at LTFV, and to be subsidized by
the governments of China and India.
Background
The Commission, pursuant to sections
705(b) and 735(b) of the Act (19 U.S.C.
1671d(b) and 19 U.S.C. 1673d(b)),
instituted these investigations effective
January 17, 2018, following receipt of a
petition filed with the Commission and
Commerce by American Cast Iron Pipe
Company (Birmingham, Alabama), Berg
Steel Pipe Corp. (Panama City, Florida),
Berg Spiral Pipe Corp. (Mobile,
Alabama), Dura-Bond Industries, Inc.
(Export, Pennsylvania), Skyline Steel
(Newington, Virginia), and Stupp
Corporation (Baton Rouge, Louisiana).
The final phase of the investigations
was scheduled by the Commission
following notification of preliminary
determinations by Commerce that
imports of large diameter welded pipe
from China, India, Korea, and Turkey
were subsidized within the meaning of
section 703(b) of the Act (19 U.S.C.
1671b(b)) and that imports of large
diameter welded pipe from Canada,
China, Greece, India, Korea, and Turkey
were being sold at LTFV within the
meaning of 733(b) of the Act (19 U.S.C.
1673b(b)). Notice of the scheduling of
PO 00000
Frm 00088
Fmt 4703
Sfmt 4703
1785
the final phase of the Commission’s
investigations and of a public hearing to
be held in connection therewith was
given by posting copies of the notice in
the Office of the Secretary, U.S.
International Trade Commission,
Washington, DC, and by publishing the
notice in the Federal Register on
September 6, 2018 (83 FR 45279).3 The
hearing was held in Washington, DC, on
November 6, 2018, and all persons who
requested the opportunity were
permitted to appear in person or by
counsel.
The Commission made these
determinations pursuant to sections
705(b) and 735(b) of the Act (19 U.S.C.
1671d(b) and 19 U.S.C. 1673d(b)). It
completed and filed its determinations
in these investigations on January 30,
2019. The views of the Commission are
contained in USITC Publication 4859
(January 2019), entitled Large Diameter
Welded Pipe from China and India,
Investigation Nos. 701–TA–593 and 594
and 731–TA–1402 and 1404 (Final).
By order of the Commission.
Issued: January 30, 2019.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2019–01024 Filed 2–4–19; 8:45 am]
BILLING CODE P
INTERNATIONAL TRADE
COMMISSION
Notice of Receipt of Complaint;
Solicitation of Comments Relating to
the Public Interest
U.S. International Trade
Commission.
ACTION: Notice.
AGENCY:
Notice is hereby given that
the U.S. International Trade
Commission has received a complaint
entitled Certain Taurine (2Aminoethanesulfonic Acid), Methods of
Production and Processes for Making
the Same, and Products Containing the
Same, DN 3360; the Commission is
soliciting comments on any public
interest issues raised by the complaint
or complainant’s filing pursuant to the
Commission’s Rules of Practice and
Procedure.
SUMMARY:
Lisa
R. Barton, Secretary to the Commission,
U.S. International Trade Commission,
500 E Street SW, Washington, DC
FOR FURTHER INFORMATION CONTACT:
3 Due to the lapse in appropriations and ensuing
cessation of Commission operations, all import
injury investigations conducted under authority of
Title VII of the Tariff Act of 1930 accordingly have
been tolled pursuant to 19 U.S.C. 1671d(b)(2),
1673d(b)(2).
E:\FR\FM\05FEN1.SGM
05FEN1
1786
Federal Register / Vol. 84, No. 24 / Tuesday, February 5, 2019 / Notices
20436, telephone (202) 205–2000. The
public version of the complaint can be
accessed on the Commission’s
Electronic Document Information
System (EDIS) at https://edis.usitc.gov,
and will be available for inspection
during official business hours (8:45 a.m.
to 5:15 p.m.) in the Office of the
Secretary, U.S. International Trade
Commission, 500 E Street SW,
Washington, DC 20436, telephone (202)
205–2000.
General information concerning the
Commission may also be obtained by
accessing its internet server at United
States International Trade Commission
(USITC) at https://www.usitc.gov. The
public record for this investigation may
be viewed on the Commission’s
Electronic Document Information
System (EDIS) at https://edis.usitc.gov.
Hearing-impaired persons are advised
that information on this matter can be
obtained by contacting the
Commission’s TDD terminal on (202)
205–1810.
SUPPLEMENTARY INFORMATION: The
Commission has received a complaint
and a submission pursuant to § 210.8(b)
of the Commission’s Rules of Practice
and Procedure filed on behalf of
Vitaworks IP, LLC; Vitaworks, LLC; and
Dr. Songzhou Hu on January 30, 2019.
The complaint alleges violations of
section 337 of the Tariff Act of 1930 (19
U.S.C. 1337) in the importation into the
United States, the sale for importation,
and the sale within the United States
after importation of certain taurine (2aminoethanesulfonic acid), methods of
production and processes for making
the same, and products containing the
same. The complaint names as
respondents: A to Z Nutrition, Inc. of
Miramar, FL; Ampak Company, Inc. of
Larchmont, NY; Armada Nutrition LLC
of Spring Hill, TN; Atlantic Chemicals
Trading of North America, Inc. of
Boston, MA; Crossroad Ingredients LLC
of Fairfield, NJ; Emote International,
Inc. of La Verne, CA; Epikix, Inc. of
Irvine, CA; Fuerst Day Lawson (USA),
Ltd. of England; Glanbia Nutritional
(NA) Inc. of Carlsbad, CA; Greating
Shipping Co. of Alhambra, CA; Green
Wave Ingredients, Inc. of La Mirada, CA;
Hard Eight Nutrition, LLC of Henderson,
NV; Fuchi Pharmaceutical Co., Ltd. d/b/
a Hubei Grand Life Science and
Technology Co., Ltd. of China; Jiangyin
Huachang Food Additive Co., Ltd. of
China; Natural Ingredient Corp. of
Pasadena, CA; JSW Enterprises, LLC d/
b/a Nutravative Ingredients of Allen,
TX; N.V.E., Inc. a/k/a N.V. E.
Pharmaceuticals, Inc. of Andover, NJ;
Pacific Rainbow International, Inc. of
City of Industry, CA; Pharmachem
VerDate Sep<11>2014
17:22 Feb 04, 2019
Jkt 247001
Laboratories, Inc. of Kearny, NJ; Prinova
USA, LLC of Carol Stream, IL; Qianjiang
Yongan Pharma. Co., Ltd. of China; SEM
Minerals, L.P. of Quincy, IL; Signo, LLC
of Houston, TX; Stauber Holdings, Inc.,
f/k/a Stauber Performance Ingredients,
Inc. of Fullerton, CA; Shandong Xinhua
Pharmaceutical USA, Inc. d/b/a SX
Pharma of South El Monte, CA;
Uniprime International, LLC of
Eatontown, NJ; and Wild Flavors, Inc. of
Erlanger, KY. The complainant requests
that the Commission issue a limited
exclusion order, cease and desist orders
and impose a bond during the 60-day
review period pursuant to 19 U.S.C.
1337(j).
Proposed respondents, other
interested parties, and members of the
public are invited to file comments, not
to exceed five (5) pages in length,
inclusive of attachments, on any public
interest issues raised by the complaint
or § 210.8(b) filing. Comments should
address whether issuance of the relief
specifically requested by the
complainant in this investigation would
affect the public health and welfare in
the United States, competitive
conditions in the United States
economy, the production of like or
directly competitive articles in the
United States, or United States
consumers.
In particular, the Commission is
interested in comments that:
(i) Explain how the articles
potentially subject to the requested
remedial orders are used in the United
States;
(ii) identify any public health, safety,
or welfare concerns in the United States
relating to the requested remedial
orders;
(iii) identify like or directly
competitive articles that complainant,
its licensees, or third parties make in the
United States which could replace the
subject articles if they were to be
excluded;
(iv) indicate whether complainant,
complainant’s licensees, and/or third
party suppliers have the capacity to
replace the volume of articles
potentially subject to the requested
exclusion order and/or a cease and
desist order within a commercially
reasonable time; and
(v) explain how the requested
remedial orders would impact United
States consumers.
Written submissions on the public
interest must be filed no later than by
close of business, eight calendar days
after the date of publication of this
notice in the Federal Register. There
will be further opportunities for
comment on the public interest after the
issuance of any final initial
PO 00000
Frm 00089
Fmt 4703
Sfmt 4703
determination in this investigation. Any
written submissions on other issues
should be filed no later than by close of
business nine calendar days after the
date of publication of this notice in the
Federal Register. Complainant may file
a reply to any written submission no
later than the date on which
complainant’s reply would be due
under § 210.8(c)(2) of the Commission’s
Rules of Practice and Procedure (19 CFR
210.8(c)(2)).
Persons filing written submissions
must file the original document
electronically on or before the deadlines
stated above and submit 8 true paper
copies to the Office of the Secretary by
noon the next day pursuant to § 210.4(f)
of the Commission’s Rules of Practice
and Procedure (19 CFR 210.4(f)).
Submissions should refer to the docket
number (‘‘Docket No. 3360) in a
prominent place on the cover page and/
or the first page. (See Handbook for
Electronic Filing Procedures, Electronic
Filing Procedures).1 Persons with
questions regarding filing should
contact the Secretary (202–205–2000).
Any person desiring to submit a
document to the Commission in
confidence must request confidential
treatment. All such requests should be
directed to the Secretary to the
Commission and must include a full
statement of the reasons why the
Commission should grant such
treatment. See 19 CFR 201.6. Documents
for which confidential treatment by the
Commission is properly sought will be
treated accordingly. All such requests
should be directed to the Secretary to
the Commission and must include a full
statement of the reasons why the
Commission should grant such
treatment. See 19 CFR 201.6. Documents
for which confidential treatment by the
Commission is properly sought will be
treated accordingly. All information,
including confidential business
information and documents for which
confidential treatment is properly
sought, submitted to the Commission for
purposes of this Investigation may be
disclosed to and used: (i) By the
Commission, its employees and Offices,
and contract personnel (a) for
developing or maintaining the records
of this or a related proceeding, or (b) in
internal investigations, audits, reviews,
and evaluations relating to the
programs, personnel, and operations of
the Commission including under 5
U.S.C. Appendix 3; or (ii) by U.S.
government employees and contract
1 Handbook for Electronic Filing Procedures:
https://www.usitc.gov/documents/handbook_on_
filing_procedures.pdf.
E:\FR\FM\05FEN1.SGM
05FEN1
Federal Register / Vol. 84, No. 24 / Tuesday, February 5, 2019 / Notices
personnel,2 solely for cybersecurity
purposes. All nonconfidential written
submissions will be available for public
inspection at the Office of the Secretary
and on EDIS.3
This action is taken under the
authority of section 337 of the Tariff Act
of 1930, as amended (19 U.S.C. 1337),
and of §§ 201.10 and 210.8(c) of the
Commission’s Rules of Practice and
Procedure (19 CFR 201.10, 210.8(c)).
By order of the Commission.
Issued: January 31, 2019.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2019–01120 Filed 2–4–19; 8:45 am]
BILLING CODE 7020–02–P
INTERNATIONAL TRADE
COMMISSION
Notice of Receipt of Complaint;
Solicitation of Comments Relating to
the Public Interest
U.S. International Trade
Commission.
ACTION: Notice.
AGENCY:
Notice is hereby given that
the U.S. International Trade
Commission has received a complaint
entitled Certain Botulinum Toxin
Products, Processes for Manufacturing
or Relating to Same and Certain
Products Containing the Same, DN
3359; the Commission is soliciting
comments on any public interest issues
raised by the complaint or
complainant’s filing pursuant to the
Commission’s Rules of Practice and
Procedure.
FOR FURTHER INFORMATION CONTACT: Lisa
R. Barton, Secretary to the Commission,
U.S. International Trade Commission,
500 E Street SW, Washington, DC
20436, telephone (202) 205–2000. The
public version of the complaint can be
accessed on the Commission’s
Electronic Document Information
System (EDIS) at https://edis.usitc.gov,
and will be available for inspection
during official business hours (8:45 a.m.
to 5:15 p.m.) in the Office of the
Secretary, U.S. International Trade
Commission, 500 E Street SW,
Washington, DC 20436, telephone (202)
205–2000.
General information concerning the
Commission may also be obtained by
accessing its internet server at United
States International Trade Commission
(USITC) at https://www.usitc.gov. The
SUMMARY:
2 All contract personnel will sign appropriate
nondisclosure agreements.
3 Electronic Document Information System
(EDIS): https://edis.usitc.gov.
VerDate Sep<11>2014
17:22 Feb 04, 2019
Jkt 247001
public record for this investigation may
be viewed on the Commission’s
Electronic Document Information
System (EDIS) at https://edis.usitc.gov.
Hearing-impaired persons are advised
that information on this matter can be
obtained by contacting the
Commission’s TDD terminal on (202)
205–1810.
SUPPLEMENTARY INFORMATION: The
Commission has received a complaint
and a submission pursuant to § 210.8(b)
of the Commission’s Rules of Practice
and Procedure filed on behalf of
Medytox Inc., Allergan plc, and
Allergan, Inc. on January 30, 2019. The
complaint alleges violations of section
337 of the Tariff Act of 1930 (19 U.S.C.
1337) in the importation into the United
States, the sale for importation, and the
sale within the United States after
importation of certain botulinum toxin
products, processes for manufacturing
or relating to same and certain products
containing the same. The complaint
names as respondents: Daewoong
Pharmaceuticals Co., Ltd of South
Korea; Daewoong Co., Ltd. of South
Korea; and Evolus, Inc. of Irvine, CA.
The complainant requests that the
Commission issue a limited exclusion
order, cease and desist orders and
impose a bond during the 60-day review
period pursuant to 19 U.S.C. 1337(j).
Proposed respondents, other
interested parties, and members of the
public are invited to file comments, not
to exceed five (5) pages in length,
inclusive of attachments, on any public
interest issues raised by the complaint
or § 210.8(b) filing. Comments should
address whether issuance of the relief
specifically requested by the
complainant in this investigation would
affect the public health and welfare in
the United States, competitive
conditions in the United States
economy, the production of like or
directly competitive articles in the
United States, or United States
consumers.
In particular, the Commission is
interested in comments that:
(i) Explain how the articles
potentially subject to the requested
remedial orders are used in the United
States;
(ii) identify any public health, safety,
or welfare concerns in the United States
relating to the requested remedial
orders;
(iii) identify like or directly
competitive articles that complainant,
its licensees, or third parties make in the
United States which could replace the
subject articles if they were to be
excluded;
(iv) indicate whether complainant,
complainant’s licensees, and/or third
PO 00000
Frm 00090
Fmt 4703
Sfmt 4703
1787
party suppliers have the capacity to
replace the volume of articles
potentially subject to the requested
exclusion order and/or a cease and
desist order within a commercially
reasonable time; and
(v) explain how the requested
remedial orders would impact United
States consumers.
Written submissions on the public
interest must be filed no later than by
close of business, eight calendar days
after the date of publication of this
notice in the Federal Register. There
will be further opportunities for
comment on the public interest after the
issuance of any final initial
determination in this investigation. Any
written submissions on other issues
should be filed no later than by close of
business nine calendar days after the
date of publication of this notice in the
Federal Register. Complainant may file
a reply to any written submission no
later than the date on which
complainant’s reply would be due
under § 210.8(c)(2) of the Commission’s
Rules of Practice and Procedure (19 CFR
210.8(c)(2)).
Persons filing written submissions
must file the original document
electronically on or before the deadlines
stated above and submit 8 true paper
copies to the Office of the Secretary by
noon the next day pursuant to § 210.4(f)
of the Commission’s Rules of Practice
and Procedure (19 CFR 210.4(f)).
Submissions should refer to the docket
number (‘‘Docket No. 3359) in a
prominent place on the cover page and/
or the first page. (See Handbook for
Electronic Filing Procedures, Electronic
Filing Procedures).1 Persons with
questions regarding filing should
contact the Secretary (202–205–2000).
Any person desiring to submit a
document to the Commission in
confidence must request confidential
treatment. All such requests should be
directed to the Secretary to the
Commission and must include a full
statement of the reasons why the
Commission should grant such
treatment. See 19 CFR 201.6. Documents
for which confidential treatment by the
Commission is properly sought will be
treated accordingly. All such requests
should be directed to the Secretary to
the Commission and must include a full
statement of the reasons why the
Commission should grant such
treatment. See 19 CFR 201.6. Documents
for which confidential treatment by the
Commission is properly sought will be
treated accordingly. All information,
1 Handbook for Electronic Filing Procedures:
https://www.usitc.gov/documents/handbook_on_
filing_procedures.pdf.
E:\FR\FM\05FEN1.SGM
05FEN1
]]>Agencies
[Federal Register Volume 84, Number 24 (Tuesday, February 5, 2019)]
[Notices]
[Pages 1785-1787]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-01120]
-----------------------------------------------------------------------
INTERNATIONAL TRADE COMMISSION
Notice of Receipt of Complaint; Solicitation of Comments Relating
to the Public Interest
AGENCY: U.S. International Trade Commission.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: Notice is hereby given that the U.S. International Trade
Commission has received a complaint entitled Certain Taurine (2-
Aminoethanesulfonic Acid), Methods of Production and Processes for
Making the Same, and Products Containing the Same, DN 3360; the
Commission is soliciting comments on any public interest issues raised
by the complaint or complainant's filing pursuant to the Commission's
Rules of Practice and Procedure.
FOR FURTHER INFORMATION CONTACT: Lisa R. Barton, Secretary to the
Commission, U.S. International Trade Commission, 500 E Street SW,
Washington, DC
[[Page 1786]]
20436, telephone (202) 205-2000. The public version of the complaint
can be accessed on the Commission's Electronic Document Information
System (EDIS) at https://edis.usitc.gov, and will be available for
inspection during official business hours (8:45 a.m. to 5:15 p.m.) in
the Office of the Secretary, U.S. International Trade Commission, 500 E
Street SW, Washington, DC 20436, telephone (202) 205-2000.
General information concerning the Commission may also be obtained
by accessing its internet server at United States International Trade
Commission (USITC) at https://www.usitc.gov. The public record for this
investigation may be viewed on the Commission's Electronic Document
Information System (EDIS) at https://edis.usitc.gov. Hearing-impaired
persons are advised that information on this matter can be obtained by
contacting the Commission's TDD terminal on (202) 205-1810.
SUPPLEMENTARY INFORMATION: The Commission has received a complaint and
a submission pursuant to Sec. 210.8(b) of the Commission's Rules of
Practice and Procedure filed on behalf of Vitaworks IP, LLC; Vitaworks,
LLC; and Dr. Songzhou Hu on January 30, 2019. The complaint alleges
violations of section 337 of the Tariff Act of 1930 (19 U.S.C. 1337) in
the importation into the United States, the sale for importation, and
the sale within the United States after importation of certain taurine
(2-aminoethanesulfonic acid), methods of production and processes for
making the same, and products containing the same. The complaint names
as respondents: A to Z Nutrition, Inc. of Miramar, FL; Ampak Company,
Inc. of Larchmont, NY; Armada Nutrition LLC of Spring Hill, TN;
Atlantic Chemicals Trading of North America, Inc. of Boston, MA;
Crossroad Ingredients LLC of Fairfield, NJ; Emote International, Inc.
of La Verne, CA; Epikix, Inc. of Irvine, CA; Fuerst Day Lawson (USA),
Ltd. of England; Glanbia Nutritional (NA) Inc. of Carlsbad, CA;
Greating Shipping Co. of Alhambra, CA; Green Wave Ingredients, Inc. of
La Mirada, CA; Hard Eight Nutrition, LLC of Henderson, NV; Fuchi
Pharmaceutical Co., Ltd. d/b/a Hubei Grand Life Science and Technology
Co., Ltd. of China; Jiangyin Huachang Food Additive Co., Ltd. of China;
Natural Ingredient Corp. of Pasadena, CA; JSW Enterprises, LLC d/b/a
Nutravative Ingredients of Allen, TX; N.V.E., Inc. a/k/a N.V. E.
Pharmaceuticals, Inc. of Andover, NJ; Pacific Rainbow International,
Inc. of City of Industry, CA; Pharmachem Laboratories, Inc. of Kearny,
NJ; Prinova USA, LLC of Carol Stream, IL; Qianjiang Yongan Pharma. Co.,
Ltd. of China; SEM Minerals, L.P. of Quincy, IL; Signo, LLC of Houston,
TX; Stauber Holdings, Inc., f/k/a Stauber Performance Ingredients, Inc.
of Fullerton, CA; Shandong Xinhua Pharmaceutical USA, Inc. d/b/a SX
Pharma of South El Monte, CA; Uniprime International, LLC of Eatontown,
NJ; and Wild Flavors, Inc. of Erlanger, KY. The complainant requests
that the Commission issue a limited exclusion order, cease and desist
orders and impose a bond during the 60-day review period pursuant to 19
U.S.C. 1337(j).
Proposed respondents, other interested parties, and members of the
public are invited to file comments, not to exceed five (5) pages in
length, inclusive of attachments, on any public interest issues raised
by the complaint or Sec. 210.8(b) filing. Comments should address
whether issuance of the relief specifically requested by the
complainant in this investigation would affect the public health and
welfare in the United States, competitive conditions in the United
States economy, the production of like or directly competitive articles
in the United States, or United States consumers.
In particular, the Commission is interested in comments that:
(i) Explain how the articles potentially subject to the requested
remedial orders are used in the United States;
(ii) identify any public health, safety, or welfare concerns in the
United States relating to the requested remedial orders;
(iii) identify like or directly competitive articles that
complainant, its licensees, or third parties make in the United States
which could replace the subject articles if they were to be excluded;
(iv) indicate whether complainant, complainant's licensees, and/or
third party suppliers have the capacity to replace the volume of
articles potentially subject to the requested exclusion order and/or a
cease and desist order within a commercially reasonable time; and
(v) explain how the requested remedial orders would impact United
States consumers.
Written submissions on the public interest must be filed no later
than by close of business, eight calendar days after the date of
publication of this notice in the Federal Register. There will be
further opportunities for comment on the public interest after the
issuance of any final initial determination in this investigation. Any
written submissions on other issues should be filed no later than by
close of business nine calendar days after the date of publication of
this notice in the Federal Register. Complainant may file a reply to
any written submission no later than the date on which complainant's
reply would be due under Sec. 210.8(c)(2) of the Commission's Rules of
Practice and Procedure (19 CFR 210.8(c)(2)).
Persons filing written submissions must file the original document
electronically on or before the deadlines stated above and submit 8
true paper copies to the Office of the Secretary by noon the next day
pursuant to Sec. 210.4(f) of the Commission's Rules of Practice and
Procedure (19 CFR 210.4(f)). Submissions should refer to the docket
number (``Docket No. 3360) in a prominent place on the cover page and/
or the first page. (See Handbook for Electronic Filing Procedures,
Electronic Filing Procedures).\1\ Persons with questions regarding
filing should contact the Secretary (202-205-2000).
---------------------------------------------------------------------------
\1\ Handbook for Electronic Filing Procedures: https://www.usitc.gov/documents/handbook_on_filing_procedures.pdf.
---------------------------------------------------------------------------
Any person desiring to submit a document to the Commission in
confidence must request confidential treatment. All such requests
should be directed to the Secretary to the Commission and must include
a full statement of the reasons why the Commission should grant such
treatment. See 19 CFR 201.6. Documents for which confidential treatment
by the Commission is properly sought will be treated accordingly. All
such requests should be directed to the Secretary to the Commission and
must include a full statement of the reasons why the Commission should
grant such treatment. See 19 CFR 201.6. Documents for which
confidential treatment by the Commission is properly sought will be
treated accordingly. All information, including confidential business
information and documents for which confidential treatment is properly
sought, submitted to the Commission for purposes of this Investigation
may be disclosed to and used: (i) By the Commission, its employees and
Offices, and contract personnel (a) for developing or maintaining the
records of this or a related proceeding, or (b) in internal
investigations, audits, reviews, and evaluations relating to the
programs, personnel, and operations of the Commission including under 5
U.S.C. Appendix 3; or (ii) by U.S. government employees and contract
[[Page 1787]]
personnel,\2\ solely for cybersecurity purposes. All nonconfidential
written submissions will be available for public inspection at the
Office of the Secretary and on EDIS.\3\
---------------------------------------------------------------------------
\2\ All contract personnel will sign appropriate nondisclosure
agreements.
\3\ Electronic Document Information System (EDIS): https://edis.usitc.gov.
---------------------------------------------------------------------------
This action is taken under the authority of section 337 of the
Tariff Act of 1930, as amended (19 U.S.C. 1337), and of Sec. Sec.
201.10 and 210.8(c) of the Commission's Rules of Practice and Procedure
(19 CFR 201.10, 210.8(c)).
By order of the Commission.
Issued: January 31, 2019.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2019-01120 Filed 2-4-19; 8:45 am]
BILLING CODE 7020-02-P
